NANOG and acute myeloid leukemia: Lastly, treating primary AML cells by BMP4 allows correlation in the same cells of the BMP4-increased expression of BMPR1A, ΔNp73, and NANOG with the amplification of cells with stemness features identified by the LTC-IC assay (Supplemental Table S4).